Package 70748-278-06

Brand: topiramate

Generic: topiramate
NDC Package

Package Facts

Identity

Package NDC 70748-278-06
Digits Only 7074827806
Product NDC 70748-278
Product ID 70748-278_8eaf61e7-2317-45ff-9cb0-18d2dbddc140
Description

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70748-278-06)

Marketing

Marketing Status
Marketed Since 2026-02-03
Brand topiramate
Generic topiramate
Sample Package No

Linked Drug Pages (1)

Topiramate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "8eaf61e7-2317-45ff-9cb0-18d2dbddc140", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["1436239", "1437278", "1437283", "1437288"], "spl_set_id": ["e310afcd-1260-434e-a994-34549c789d99"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70748-278-06)", "package_ndc": "70748-278-06", "marketing_start_date": "20260203"}], "brand_name": "Topiramate", "product_id": "70748-278_8eaf61e7-2317-45ff-9cb0-18d2dbddc140", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "70748-278", "generic_name": "Topiramate", "labeler_name": "Lupin Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "200 mg/1"}], "application_number": "ANDA215561", "marketing_category": "ANDA", "marketing_start_date": "20260203", "listing_expiration_date": "20271231"}